Cargando…
o-Vanillin Modulates Cell Phenotype and Extracellular Vesicles of Human Mesenchymal Stem Cells and Intervertebral Disc Cells
Human mesenchymal stem cell (hMSC) and extracellular vesicle (EV) therapy is a promising treatment for discogenic low back pain (LBP). Although promising, major obstacles remain to be overcome. Cellular senescence reduces self-renewal and multipotent potentials, and the senescence-associated secreto...
Autores principales: | Li, Li, Sheng, Kai, Mannarino, Matthew, Jarzem, Peter, Cherif, Hosni, Haglund, Lisbet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688801/ https://www.ncbi.nlm.nih.gov/pubmed/36429018 http://dx.doi.org/10.3390/cells11223589 |
Ejemplares similares
-
Toll-like receptor 2 induced senescence in intervertebral disc cells of patients with back pain can be attenuated by o-vanillin
por: Mannarino, Matthew, et al.
Publicado: (2021) -
Single-Cell RNA-Seq Analysis of Cells from Degenerating and Non-Degenerating Intervertebral Discs from the Same Individual Reveals New Biomarkers for Intervertebral Disc Degeneration
por: Cherif, Hosni, et al.
Publicado: (2022) -
Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro
por: Cherif, Hosni, et al.
Publicado: (2019) -
Senotherapeutic drugs for human intervertebral disc degeneration and low back pain
por: Cherif, Hosni, et al.
Publicado: (2020) -
Senolytic Combination Treatment Is More Potent Than Single Drugs in Reducing Inflammatory and Senescence Burden in Cells from Painful Degenerating IVDs
por: Mannarino, Matthew, et al.
Publicado: (2023)